Susan Collins actually said...
What we are finding is that a lot of these companies are not doing the manufacturing, and so it is a very new and interesting business model, and I am convinced that it is one that is really negative for patients, providers, hospitals, and for Federal and State health care programs.
Context
Expressing concerns about the negative effects of new pharmaceutical business models on healthcare.
01/27/2016